Literature DB >> 25879010

Dysbetalipoproteinemia: Two cases report and a diagnostic algorithm.

Anastazia Kei1, George Miltiadous1, Eleni Bairaktari1, Marilena Hadjivassiliou1, Marios Cariolou1, Moses Elisaf1.   

Abstract

Dysbetalipoproteinemia is a rare familial dyslipidemia characterized by approximately equally elevated serum cholesterol and triglyceride levels due to accumulated remnant lipoproteins in apolipoprotein E2/E2 homozygotes. It is associated with an increased risk for premature cardiovascular disease. Thus, making a diagnosis of dysbetalipoproteinemia aids in assessing cardiovascular risk correctly and allows for genetic counseling. However, the diagnostic work-up can be challenging. Diagnosis of dysbetalipoproteinemia should be considered in patients mixed dyslipidemia when the apolipoprotein B concentration is relatively low in relation to the total cholesterol concentration or when there is significant disparity between the calculated low density lipoprotein (LDL) and directly measured LDL cholesterol concentrations. Other indices are also informative in the diagnostic process. We present herein two phenotypically different cases (a 44-year-old man with severe hypertriglyceridemia and a 49-year-old woman with mixed dyslipidemia) of genotypically proven familial dysbetalipoproteinemia and a diagnostic algorithm of the disease.

Entities:  

Keywords:  Chylomicronemia; Dysbetalipoproteinemia; Hyperlipoproteinemia type III; Hypertriglyceridemia

Year:  2015        PMID: 25879010      PMCID: PMC4391008          DOI: 10.12998/wjcc.v3.i4.371

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  24 in total

1.  Acquired myeloma-associated Type III hyperlipidaemia treated by nonmyeloablative HLA-identical sibling allogeneic stem cell transplant using a donor with essential thrombocythaemia (ET): evidence of engraftment without manifestation of ET in recipient.

Authors:  L Chee; R L Spearing; C M Morris; M McDonald; V Hanrahan; A Ebbett; R Scott; C Florkowski; T Walmsley; W N Patton
Journal:  Bone Marrow Transplant       Date:  2005-06       Impact factor: 5.483

2.  Remnant lipoproteins induce endothelial plasminogen activator inhibitor-1.

Authors:  A M Sawka; R J Singh; H J Hiddinga; J P McConnell; N L Eberhardt; N M Caplice; T O'Brien
Journal:  Biochem Biophys Res Commun       Date:  2001-07-06       Impact factor: 3.575

Review 3.  Lipoprotein receptors and cholesterol homeostasis.

Authors:  R W Mahley; T L Innerarity
Journal:  Biochim Biophys Acta       Date:  1983-05-24

4.  Apolipoprotein E mutants, hyperlipidemia and arteriosclerosis.

Authors:  G Utermann
Journal:  Adv Exp Med Biol       Date:  1985       Impact factor: 2.622

5.  Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease.

Authors:  Paul N Hopkins; Lily L Wu; Steven C Hunt; Eliot A Brinton
Journal:  J Am Coll Cardiol       Date:  2005-04-05       Impact factor: 24.094

Review 6.  Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.

Authors:  Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Frank Sacks; Mohammad Hassan Murad; Anton F H Stalenhoef
Journal:  J Clin Endocrinol Metab       Date:  2012-09       Impact factor: 5.958

Review 7.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

8.  Non-denaturing polyacrylamide gradient gel electrophoresis for the diagnosis of dysbetalipoproteinemia.

Authors:  Dirk J Blom; Pamela Byrnes; Sheena Jones; A David Marais
Journal:  J Lipid Res       Date:  2003-01       Impact factor: 5.922

Review 9.  Hypertriglyceridemia: its etiology, effects and treatment.

Authors:  George Yuan; Khalid Z Al-Shali; Robert A Hegele
Journal:  CMAJ       Date:  2007-04-10       Impact factor: 8.262

10.  Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.

Authors:  Børge G Nordestgaard; M John Chapman; Steve E Humphries; Henry N Ginsberg; Luis Masana; Olivier S Descamps; Olov Wiklund; Robert A Hegele; Frederick J Raal; Joep C Defesche; Albert Wiegman; Raul D Santos; Gerald F Watts; Klaus G Parhofer; G Kees Hovingh; Petri T Kovanen; Catherine Boileau; Maurizio Averna; Jan Borén; Eric Bruckert; Alberico L Catapano; Jan Albert Kuivenhoven; Päivi Pajukanta; Kausik Ray; Anton F H Stalenhoef; Erik Stroes; Marja-Riitta Taskinen; Anne Tybjærg-Hansen
Journal:  Eur Heart J       Date:  2013-08-15       Impact factor: 29.983

View more
  2 in total

Review 1.  Percutaneous Coronary Intervention in Familial Hypercholesterolemia Is Understudied.

Authors:  Leo Ungar; David Sanders; Brian Becerra; Ailin Barseghian
Journal:  Front Cardiovasc Med       Date:  2018-08-30

2.  Strawberry milk-like blood in a subject with diabetic lipemia: dramatic change to transparent color after insulin therapy.

Authors:  Atsushi Obata; Shinji Kamei; Seizo Okauchi; Tomohiko Kimura; Hidenori Hirukawa; Akihito Tanabe; Tomoe Kinoshita; Kenji Kohara; Fuminori Tatsumi; Masashi Shimoda; Shuhei Nakanishi; Tomoatsu Mune; Kohei Kaku; Hideaki Kaneto
Journal:  Springerplus       Date:  2016-09-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.